JW Choongwae Pharm, applied for product approval of’Rivarojet’, a new complex drug for hyperlipidemia
JW Choongwae Pharmaceutical’s new complex drug for hyperlipidemia, Rivarojet product license application
Chong Kun Dang, beyond the Ministry of Food and Drug Safety… The 2nd Korean Corona 19 drug candidate is